TerrAscend (OTCMKTS:TSNDF – Get Free Report) is one of 43 public companies in the “Agricultural production – crops” industry, but how does it compare to its rivals? We will compare TerrAscend to similar companies based on the strength of its analyst recommendations, earnings, institutional ownership, valuation, risk, dividends and profitability.
Profitability
This table compares TerrAscend and its rivals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
TerrAscend | -23.95% | -31.48% | -11.40% |
TerrAscend Competitors | -98.15% | -2,439.03% | -14.56% |
Earnings & Valuation
This table compares TerrAscend and its rivals gross revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
TerrAscend | $317.33 million | -$95.54 million | -1.68 |
TerrAscend Competitors | $1.22 billion | -$827,419.35 | 6.95 |
Institutional & Insider Ownership
5.8% of TerrAscend shares are held by institutional investors. Comparatively, 20.7% of shares of all “Agricultural production – crops” companies are held by institutional investors. 31.9% of TerrAscend shares are held by insiders. Comparatively, 16.0% of shares of all “Agricultural production – crops” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Analyst Ratings
This is a summary of recent ratings for TerrAscend and its rivals, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
TerrAscend | 0 | 1 | 0 | 1 | 3.00 |
TerrAscend Competitors | 315 | 258 | 605 | 34 | 2.30 |
As a group, “Agricultural production – crops” companies have a potential upside of 52.71%. Given TerrAscend’s rivals higher probable upside, analysts plainly believe TerrAscend has less favorable growth aspects than its rivals.
Risk & Volatility
TerrAscend has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, TerrAscend’s rivals have a beta of -19.60, suggesting that their average share price is 2,060% less volatile than the S&P 500.
Summary
TerrAscend beats its rivals on 7 of the 13 factors compared.
About TerrAscend
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.